Skip to main content
OpenTrials

Clinical trial condition

Myeloproliferative Disorders

Explore clinical trials studying Myeloproliferative Disorders. Study availability and eligibility vary by location and protocol.

1,108 public trials 144 recruiting studies
Refine in advanced search Browse all conditions

Myeloproliferative Disorders trial results

Completed

Study of ProTmune for Allogeneic HCT in Adult Patients With Hematologic Malignancies

NCT02743351

Conditions
Acute Graft-versus-host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +35 more
Locations
  • University of Alabama Birmingham, Alabama, United States
  • City of Hope Duarte, California, United States
  • University of California, San Diego (UCSD) Moores Cancer Center San Diego, California, United States
  • University of Chicago Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Bosutinib in Elderly Chronic Myeloid Leukemia

NCT02810990

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy
  • Azienda Ospedaliero - Universitaria Ospedali Riuniti Umberto I - G.M. LANCISI - G. SALESI Ancona, Italy
  • UO Ematologia con trapianto-Università degli Studi di Bari Aldo Moro Bari, Italy
  • Fausto Castagnetti Bologna, Italy
View all 45 locations
View Trial Details
Completed

Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

NCT01607892

Conditions
Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +35 more
Locations
  • Moffitt Cancer Center Tampa, Florida, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University School of Medicine St Louis, Missouri, United States
  • Hackensack University Medical Center Hackensack, New Jersey, United States
View Trial Details
Completed

European Registry for Myeloproliferative Neoplasms (MPNs) - Update of ERNEST Study

NCT04153305

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • AOU Careggi Florence, FI, Italy
  • UOC Ematologia, ASST Papa Giovanni XXIII Bergamo, Lombardy, Italy
  • Divisione Ematologia, Fondazione IRCCS Policlinico San Matteo Pavia, Lombardy, Italy
  • U.O. Ematologia, Ospedale di Circolo e Fondazione Macchi Varese Varese, Lombardy, Italy
View Trial Details
Completed

Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

NCT00406393

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +21 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • UCSD Medical Center La Jolla, California, United States
  • Stanford Hospital and Clinics Stanford, California, United States
  • University of Florida College of Medicine (Shands) Gainesville, Florida, United States
View all 24 locations
View Trial Details
Completed

Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States

NCT03045120

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Phase Chronic Myeloid Leukemia, +12 more
Locations
  • Mount Sinai Hospital Chicago, Illinois, United States
  • Alexian Brothers Medical Center Elk Grove Village, Illinois, United States
  • The Cancer Institute At Alexian Brothers Elk Grove Village, Illinois, United States
  • Northwest Oncology & Hematology, SC Hoffman Estates, Illinois, United States
View all 24 locations
View Trial Details

Related conditions